GrowingStockReport.com

Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) and Autodesk, Inc. (NASDAQ:ADSK) Added to Growing Stock Report's NASDAQ Gainers Watch List.

 

New York, NY -- (ReleaseWire) -- 02/20/2014 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) and Autodesk, Inc. (NASDAQ:ADSK).

Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) a development stage pharmaceutical company that focuses on the acquisition, development, and commercialization of pharmaceutical products closed up in its previous session (+4.65%) on 11,041,995 shares traded after Chelsea Therapeutics Announced FDA Accelerated Approval of NORTHERA for the Treatment of Symptomatic NOH. Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) is currently up (+597.37%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Chelsea Therapeutics International Ltd. (NASDAQ:CHTP)

Autodesk, Inc. (NASDAQ:ADSK) operates as a design software and services company worldwide closed up in its previous session (+0.65%) on 2,750,707 shares traded. Autodesk, Inc. (NASDAQ:ADSK) is currently up (+66.19%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Autodesk, Inc. (NASDAQ:ADSK)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com